13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-01-30 Event 2025-01-30 SEC 0001104659-25-007720 →

Bpifrance Participations SA Cellectis S.A. CLLS

Stake: 13.10% Shares: 10,292,653 CUSIP: 15117K103 Class: Ordinary Shares, nominal value EUR0.05 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: All of the Ordinary Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Ordinary Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Ordinary Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein. Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of the Instructions to Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
24 filings by this filer
23 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 16.80
289,618 shares short · -10.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $132K
Point72 Asset Mgmt

Post-Filing Returns · since 2025-01-30 on CLLS

+1 day
+1.9%
+5 days
+3.2%
+30 days
-18.4%
+60 days
-21.5%
+90 days
+4.1%
+180 days
+77.5%

Anchor price 1.58 on closest trading day on/after 2025-01-30. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Cellectis S.A.

FiledFormFilerStakeShares
2025-01-24 SCHEDULE ASTRAZENECA PLC 44.00% 44,000,000 view →
2021-02-12 SC Bpifrance Participations SA view →

Other Filings by Bpifrance Participations SA

FiledFormIssuerStakeShares
2026-05-28 SCHEDULE 13D/A Constellium SE CSTM 6.20% 8,403,903 view →
2026-05-12 SCHEDULE 13D/A Valneva SE VALN 14,317,670 view →
2026-01-07 SCHEDULE DBV Technologies S.A. DBVTF 4.70% 10,898,595 view →
2026-01-05 SCHEDULE DBV Technologies S.A. DBVTF 5.30% 10,985,372 view →
2025-02-14 SCHEDULE Stellantis N.V. STLA 10.90% 393,615,130 view →
2024-01-29 SC Stellantis N.V. STLA view →
2022-12-06 SC Innate Pharma SA IPHYF view →
2022-10-21 SC Innate Pharma SA IPHYF view →
2022-06-28 SC VectivBio Holding AG view →
2022-03-17 SC SEQUANS COMMUNICATIONS SQNS view →
2022-01-11 SC Technip Energies N.V. view →
2021-11-18 SC TechnipFMC plc FTI view →
2021-08-09 SC SEQUANS COMMUNICATIONS SQNS view →
2021-05-11 SC Technip Energies N.V. view →
2021-04-01 SC TechnipFMC plc FTI view →
2021-02-12 SC Cellectis S.A. CLLS view →
2021-02-12 SC SEQUANS COMMUNICATIONS SQNS view →
2021-02-12 SC DBV Technologies S.A. DBVTF view →
2019-12-16 SC Millendo Therapeutics, Inc. TPST view →
2019-10-15 SC DBV Technologies S.A. DBVTF view →
Showing 20 of 23

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →